The goal of this clinical trial is to explore whether additional treatments can help strengthen the participant's immune system to fight cancer caused by the H…

Cervical CarcinomaVaginal CarcinomaVulvar Carcinoma+1 more

~Estimated

~$10 – $6,250

Baylor College of MedicineNCT06686043

Phase 2

Neoadjuvant Chemotherapy and PD-1 Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

The NeoScorch HN study is a single institution multisite phase II trial including 3 cohorts of 25 patients each for patients with newly diagnosed locoregionall…

Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more

~Estimated

~$10 – $6,250

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07209189